OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Release Date
2024
(3)
2022
(2)
2021
(1)
2018
(1)
2014
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Framework to construct and interpret latent class trajectory modelling.
Not available
S-EPMC6042544
|
biostudies-literature
Cite
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.
Not available
S-EPMC4154862
|
biostudies-literature
Cite
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.
Not available
S-EPMC8832801
|
biostudies-literature
Cite
Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy.
Not available
S-EPMC9253904
|
biostudies-literature
Cite
The empty pelvis syndrome: a core data set from the PelvEx collaborative.
Not available
S-EPMC10921833
|
biostudies-literature
Cite
Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II).
Not available
S-EPMC8179511
|
biostudies-literature
Cite
Behavioral Outcomes and Neurodevelopmental Disorders Among Children of Women With Epilepsy.
Not available
S-EPMC10660252
|
biostudies-literature
Cite
Beating the empty pelvis syndrome: the PelvEx Collaborative core outcome set study protocol.
Not available
S-EPMC10860036
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets